Newsroom

NewYork-Presbyterian/Hudson Valley Hospital and the Ashikari Breast Center will hold the 1^st Annual Dr. Roy Ashikari Cancer Symposium on September 28^th at Doral Arrowwood Conference Center in Rye Brook, NY.

"Advancements in the Prevention and Treatment of Breast Cancer," will look at the latest treatments for the disease with much of the day’s presentations focusing on the topic of genetics and its growing role in the treatment of breast cancer. The keynote speaker will be Lee B. Riley, MD, PhD, FACS, who will speak on "Genomic Profiling in Practice-Present and Future Trendsin Breast Cancer Genomics."

"As a leader in the field of Breast Cancer, the Ashikari Breast Center is committed to sharing the latest developments in our field with our colleagues and we are excited to offer this free CME opportunity to medical professionals in our area," said Dr. Andrew Ashikari of the Ashikari Breast Center. "This is the first of, what we hope, will be a continued series of cancer education symposiums in cooperation with the Cheryl R. Lindenbaum Cancer Center at NewYork-Presbyterian/Hudson Valley Hospital."

The symposium, from 8 a.m. to 2 p.m., will feature eight presentations by noted local physicians and include a continental breakfast and lunch. The keynote speaker, Dr. Riley, will speak on the exciting new area of Genomic profiling. This involves the analysis of tumors on a genetic level and the design of an individualized treatment plan. By identifying the mutations that occur in a cancer cell's genome, physicians can better understand what caused the tumor and tailor a more effective treatment. Dr. Riley is Section Chief of Surgical Oncology as well as Medical Director of Oncology at St. Luke’s Hospital in Bethlehem, Pa. He also serves as Clinical Assistant Professor of Surgery at the University of Pennsylvania School of Medicine. Dr. Riley completed his post-doctoral fellowship at MD Anderson Cancer Center. He has lectured and published extensively on advances in cancer care.

In addition to Dr. Riley, presenters will include Kutluk Otkay, MD (Fertility Issues in Women with BRCA Mutations); Sean Tedjarti, MD (Prophylactic Oophorectomy in Women with BRCA Mutation); Andrew Ashikari, MD (Prophylactic Mastectomy in Women with BRCA Mutations); C. Andrew Salzberg, MD (Breast Reconstruction for Prophylactic Mastectomy: a 12-year Experience) Chika Madu, MD (Recent Advances in Radiation Therapy for Early Stage Breast Cancer); Pond Kelemen, MD (Intra-operative radiotherapy in Early Breast Cancer) and Asim Aijaz, MD (Targeted Adjuvant Therapy for High Risk Breast Cancer).

The Cheryl R. Lindenbaum Comprehensive Cancer Center opened in November of 2011. It offers patients a comprehensive approach to treating cancer. The center’s team of physicians and medical professionals work together to design a treatment plan that coordinates all services so patients can receive treatment in one place close to home, eliminating travel time and reducing stress. The center offers radiation, infusion and support services including a nurse navigator, nutrition counseling, and integrative medicine services in a new state-of-the-art facility equipped with the latest technology and designed with comfort in mind.

The Ashikari Breast Center has earned a well-deserved reputation nationwide for expertise and successful outcomes. Founded by Dr. Roy Ashikari, a former Chief of the Breast Service at Memorial Sloan Kettering Cancer Center in Manhattan, the practice offers access to the finest physicians in the field of breast cancer care. The Center is known world -wide for the innovative one-step, nipple-sparing mastectomy, with immediate reconstruction. These renowned surgical oncologists, along with the NY Group for Plastic Surgery, pioneered this life-changing procedure.